美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Unum Therapeutics

2.35

0.0000

成交量：- -

成交額：- -

市值：9,980.31萬

市盈率：-2.73

高：2.35

開：2.35

低：2.35

收：2.35

52周最高：3.72

52周最低：0.2950

股本：4,246.94萬

流通股本：1,497.26萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.8604

每股收益(LYR):-1.0444

淨資產收益率：-69.97%

總資產收益率：-25.76%

市淨率：3.88

市盈率(LYR):-2.25

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Unum Therapeutics

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.unumrx.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Unum Therapeutics Inc.於2014年3月根據特拉華州的法律註冊成立,是一家臨床階段的生物製藥公司，專註於開發和商業化旨在利用患者免疫系統治療癌症的新型免疫治療產品。該公司的專有技術，稱為抗體偶聯T細胞受體（ACTR），是一種通用的工程細胞療法，旨在與各種腫瘤特異性抗體結合使用，以針對不同的腫瘤類型。他們的產品候選物由ACTRT細胞與臨床前或臨床開發中經批准和可商購的抗體或抗體共同施用組成。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/UMRX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"UMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UMRX\",,,,,undefined,":{"symbol":"UMRX","market":"US","secType":"STK","nameCN":"Unum Therapeutics","latestPrice":2.35,"timestamp":1601928000000,"preClose":2.35,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":14972583,"shares":42469409,"eps":-0.860372,"marketStatus":"盤後交易","change":0,"latestTime":"03-26 17:17:15 EDT","open":2.35,"high":2.35,"low":2.35,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.860372,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774569600000},"marketStatusCode":4,"symbolChange":{"newSymbol":"COGT","executeDate":"2020-10-06"},"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":2.35,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UMRX\",,,,,undefined,":{"symbol":"UMRX","floatShares":14972583,"roa":"-25.76%","roe":"-69.97%","lyrEps":-1.044378,"shares":42469409,"dividePrice":0,"high":2.35,"amplitude":0,"preClose":2.35,"low":2.35,"week52Low":0.295,"pbRate":"3.88","week52High":3.72,"institutionHeld":0,"latestPrice":2.35,"eps":-0.860372,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.860372,"open":2.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-06","symbol":"UMRX","oldSymbol":"UMRX","defaultRemindTime":1601991000000,"newSymbol":"COGT","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1601956800000},{"market":"US","date":"2020-05-11","symbol":"UMRX","fiscalQuarterEnding":"2020/03","expectedEps":-0.33,"name":null,"time":"","type":"earning","dateTimestamp":1589169600000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2020-03-26","symbol":"UMRX","fiscalQuarterEnding":"2019/12","expectedEps":-0.35,"name":null,"time":"","type":"earning","dateTimestamp":1585195200000,"reportTimeType":"","actualEps":null},{"date":"2019-08-12","symbol":"UMRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.39,"defaultRemindTime":1565640000000,"name":null,"time":"盤後","dateTimestamp":1565582400000,"actualEps":-0.31},{"market":"US","date":"2019-05-13","symbol":"UMRX","fiscalQuarterEnding":"2019/03","expectedEps":-0.31,"name":null,"time":"盤前","type":"earning","dateTimestamp":1557720000000,"reportTimeType":"pre","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UMRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UMRX","date":"2020-08-14","current":-2.731377,"percent":0.07554,"low":-4.532899,"twenty":-1.520272,"median":-0.653146,"eighty":-0.449952,"high":-0.223798,"avg":-1.16729,"sd":1.04781,"marketCap":90683610},"quantilePoints":[],"updateTime":1774528165019},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.unumrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Unum Therapeutics Inc.於2014年3月根據特拉華州的法律註冊成立,是一家臨床階段的生物製藥公司，專註於開發和商業化旨在利用患者免疫系統治療癌症的新型免疫治療產品。該公司的專有技術，稱為抗體偶聯T細胞受體（ACTR），是一種通用的工程細胞療法，旨在與各種腫瘤特異性抗體結合使用，以針對不同的腫瘤類型。他們的產品候選物由ACTRT細胞與臨床前或臨床開發中經批准和可商購的抗體或抗體共同施用組成。","exchange":"NASDAQ","name":"Unum Therapeutics","nameEN":"Unum Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"UMRX\",market:\"US\",,,undefined,":null}}